90 related articles for article (PubMed ID: 7523036)
1. Chest radiography in patients with early stage prostatic carcinoma. Effect on treatment planning and cost analysis.
Forman HP; Fox LA; Glazer HS; McClennan BL; Anderson DC; Sagel SS
Chest; 1994 Oct; 106(4):1036-41. PubMed ID: 7523036
[TBL] [Abstract][Full Text] [Related]
2. CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective?
Forman HP; Heiken JP; Brink JA; Glazer HS; Fox LA; McClennan BL
AJR Am J Roentgenol; 1994 May; 162(5):1125-8; discussion 1129-30. PubMed ID: 8165996
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
4. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy.
Graham RA; Wang S; Catalano PJ; Haller DG
Ann Surg; 1998 Jul; 228(1):59-63. PubMed ID: 9671067
[TBL] [Abstract][Full Text] [Related]
5. Routine chest radiography in a primary care setting.
Tigges S; Roberts DL; Vydareny KH; Schulman DA
Radiology; 2004 Nov; 233(2):575-8. PubMed ID: 15516621
[TBL] [Abstract][Full Text] [Related]
6. Are routine chest radiographs necessary after image-guided placement of internal jugular central venous access devices?
Chang TC; Funaki B; Szymski GX
AJR Am J Roentgenol; 1998 Feb; 170(2):335-7. PubMed ID: 9456941
[TBL] [Abstract][Full Text] [Related]
7. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.
Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
Urology; 1995 Sep; 46(3):277-89. PubMed ID: 7544931
[No Abstract] [Full Text] [Related]
8. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
[TBL] [Abstract][Full Text] [Related]
9. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
10. AUA's response to the OTA study on prostate cancer screening for elderly men.
Oncology (Williston Park); 1995 Nov; 9(11):1123. PubMed ID: 8703675
[No Abstract] [Full Text] [Related]
11. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy.
Flanigan RC; McKay TC; Olson M; Shankey TV; Pyle J; Waters WB
Urology; 1996 Sep; 48(3):428-32. PubMed ID: 8804497
[TBL] [Abstract][Full Text] [Related]
12. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program.
Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
Urology; 1995 Oct; 46(4):445-61. PubMed ID: 7571211
[No Abstract] [Full Text] [Related]
13. REDUCE-PCP study: radiographs in the emergency department utilization criteria evaluation-pediatric chest pain.
Neff J; Anderson M; Stephenson T; Young J; Hennes H; Suter R
Pediatr Emerg Care; 2012 May; 28(5):451-4. PubMed ID: 22531188
[TBL] [Abstract][Full Text] [Related]
14. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
Brandeis J; Pashos CL; Henning JM; Litwin MS
Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
[TBL] [Abstract][Full Text] [Related]
15. Future benefits and cost-effectiveness of prostate carcinoma screening. American Cancer Society.
Littrup PJ
Cancer; 1997 Nov; 80(9):1864-70. PubMed ID: 9351561
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence.
Barocas DA; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Ramsey SD
Int J Technol Assess Health Care; 2014 Oct; 30(4):345-53. PubMed ID: 25399914
[TBL] [Abstract][Full Text] [Related]
17. A multicenter evaluation of utility of chest computed tomography and bone scans in liver transplant candidates with stages I and II hepatoma.
Koneru B; Teperman LW; Manzarbeitia C; Facciuto M; Cho K; Reich D; Sheiner P; Fisher A; Noto K; Goldenberg A; Korogodsky M; Campbell D
Ann Surg; 2005 Apr; 241(4):622-8. PubMed ID: 15798464
[TBL] [Abstract][Full Text] [Related]
18. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.
Bolenz C; Gupta A; Hotze T; Ho R; Cadeddu JA; Roehrborn CG; Lotan Y
Eur Urol; 2010 Mar; 57(3):453-8. PubMed ID: 19931979
[TBL] [Abstract][Full Text] [Related]
19. [The perioperative charge equivalence of radical prostatectomy with 1-year follow up since the diagnosis of prostate cancer].
Namiki S; Ito A; Ishidoya S; Satoh M; Saito S; Arai Y; Tochigi T; Kuwahara M; Ioritani N; Koinuma N
Hinyokika Kiyo; 2004 Feb; 50(2):71-5. PubMed ID: 15101159
[TBL] [Abstract][Full Text] [Related]
20. Toward optimal use of radiographs. Should admission and preoperative chest films be routine?
Lurie P
Postgrad Med; 1987 Aug; 82(2):209-11, 214-6. PubMed ID: 3112754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
